Almirall opens UK headquarters
May 27, 2009Sales and Marketing Almirall
Spanish pharma company Almirall has opened its new UK and Ireland headquarters in West London's Stockley Park.The site will be …
Quotient buys Scottish clinical unit from Charles River
May 26, 2009Research and Development Charles River, Quotient
Contract research organisation Quotient Bioresearch has acquired a facility from Charles River Laboratories that will boost its capabilities in the …
MedeConnect launches next generation of online doctor surveys
May 21, 2009Medical Communications MedConnect
The market research arm of online doctors' community Doctors.net.uk has launched a new qualitative market research service which expands the …
Sanofi launches web TV channel
May 21, 2009Sales and Marketing Sanofi-Aventis, digi
Sanofi-Aventis has set up an online television channel to promote its business, commitment to social responsibility and employee activities. To …
Omnicom opens new healthcare coms agency
May 21, 2009Medical Communications TogoRun
Media giant the Omnicom Group has launched a TogoRun, a new healthcare communications agency with offices in London and New …
Phase III drug superior to Spiriva, says Novartis
May 21, 2009Research and Development, Sales and Marketing COPD, Novarits
Novartis says its COPD treatment has shown significant benefits over two established rivals, and could form the cornerstone of a …
Pfizer signs Indian generic deals
May 21, 2009Sales and Marketing Pfizer, generics
Pfizer has expanded its presence in the generics market with deals that see it licence 75 products from two Indian …
Mexican flu: contained but not beaten
May 21, 2009Research and Development Mexico, Vaccine, flu, pandemic
Global efforts to limit the impact of the new strain of H1N1 flu virus have proven successful, but the threat …
ABPI looks to breathe new life into industry relations
May 20, 2009Medical Communications, Sales and Marketing ABPI, doctors, industry relations, medical education, vita
The ABPI has unveiled a new proactive agenda which it hopes will help improve the industry’s reputation and relationships with …
Takeda to market new bone cancer drug
May 20, 2009Research and Development, Sales and Marketing MA, Takeda
Takeda has gained the rights to the first treatment for a new malignant bone cancer affecting children and young adults. …
Cannabis-derived MS drug filed for European approval
May 20, 2009Research and Development, Sales and Marketing GW, Sativex
Sativex, the cannabis-derived product developed by GW Pharmaceuticals, could be finally set for European approval after five years of delay. …
EFPIA plans counterfeit crackdown
May 20, 2009Manufacturing and Production, Research and Development EFPIA, counterfeits
European pharmaceutical industry association EFPIA has unveiled a new scheme to crack down on counterfeit medicines.Beginning with a trial run …
SkyePharma cuts staff at French and Swiss facilities
May 20, 2009Research and Development, Sales and Marketing Skyepharma
SkyePharma has moved ahead with plans to cut its workforce at a manufacturing plant in France by a third as …
EU gives the nod to Teva/Lonza biosimilar venture
May 18, 2009Manufacturing and Production, Sales and Marketing Lonza, Teva
The European Commission has given a green light to the formation of a joint venture company between Teva and Lonza …
The medical-marketing interface and how to bridge the gap
May 18, 2009Research and Development, Sales and Marketing marketing, medical
Drug companies are not charities and are accountable to their shareholders, as we all know. Products have to be sold …
GSK signs oncology deal with UK biotech
May 18, 2009Research and Development, Sales and Marketing GSK, Oxford Biotherapeutics
GSK has struck a deal with Oxford BioTherapeutics to develop therapies for primary, metastatic and recurring forms of cancer. The …
Sanofi-Aventis starts work on dengue fever plant
May 15, 2009Manufacturing and Production Sanofi-Aventis
Sanofi-Aventis' vaccine subsidiary Sanofi Pasteur has broken ground on a 350 million euro facility devoted to the producing a vaccine …
Sanofi-Aventis signs deal with Japanese biotech
May 15, 2009Research and Development, Sales and Marketing Sanofi-Aventis
Sanofi-Aventis has signed an early-stage research deal with biotech Kyowa Hakko Kirin, and will receive rights to its preclinical stage …
Kendle trims down as profits slump
May 15, 2009Research and Development Kendle
Contract research organisation Kendle joined many of its peers in reporting a slump in demand for its clinical research services …
Cohn & Wolfe takes on hepatitis C and substance misuse brief
May 15, 2009Medical Communications Cohn&Wolfe
PR agency Cohn & Wolfe is to handle communications for Schering-Plough's substance misuse and hepatitis C portfolio. It will work …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
